Veterinarinės medicinos centras Pifulis - Company finances
|
EUR
|
2023
From: 2023-08-24
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|
|
Financial data
|
|||
| Sales revenue | 47,979 | 363,121 | 490,857 |
| Profit before tax | 12,038 | 41,304 | 70,959 |
| Net profit | 11,436 | 35,108 | 59,606 |
| Equity | 13,936 | 49,044 | 108,650 |
| Liabilities | 34,247 | 51,747 | 89,827 |
| Non-current assets | 8,942 | 19,805 | 61,079 |
| Current assets | 39,241 | 80,986 | 137,398 |
| Total assets | 48,183 | 100,791 | 198,477 |
|
Taxes paid
|
|||
| STI taxes | 368 | 18,581 | 47,200 |
| Social insurance contributions | - | - | 8,569 |
|
Financial indicators
|
|||
| Revenue change y/y | - | +656.8% | +35.2% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 23.7% | 34.8% | 30.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 82.1% | 71.6% | 54.9% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 23.8% | 9.7% | 12.1% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 25.1% | 11.4% | 14.5% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 2.5 | 1.1 | 0.8 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 47,979 | 189,451 | 147,259 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Veterinarinės medicinos centras Pifulis - Social security debts
The company had no debts to Sodra
Veterinarinės medicinos centras Pifulis - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-08-07 | 2026-08-20 | 0.54 |
| 2026-08-03 | 2026-08-06 | 327.6 |
| 2025-08-28 | 2025-09-23 | 1.0 |
| 2025-07-28 | 2025-08-22 | 1.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Pifulis, UAB (code 306384660) is a Private Limited Liability Company operating in veterinary activities. In 2025, the company generated revenue of €490.9K and net profit of €59.6K, corresponding to a profit margin of 12.1%. Revenue increased by 35.2% year on year, while the two-year increase reached 923.1%, showing a very strong expansion from the €48.0K recorded in 2023 and €363.1K in 2024. Profitability also improved over the period, with net profit rising from €11.4K in 2023 to €35.1K in 2024 and €59.6K in 2025. The balance sheet strengthened alongside growth: total assets increased to €198.5K in 2025 from €100.8K in 2024 and €48.2K in 2023, while equity rose to €108.7K. Liabilities stood at €89.8K, giving a debt-to-equity ratio of 0.83. The equity ratio was 54.7%, asset turnover 2.47x, ROE 54.9% and ROA 30.0%. Revenue per employee was €163.6K, indicating solid productivity.